Yumanity Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Kineta

29/03/2022 14:30

* Yumanity Therapeutics Inc  YMTX.OQ  reported a quarterly
adjusted loss of 100 cents​​ per share for the quarter ended in
December. The mean expectation of three analysts for the quarter
was for a loss of $1.05 per share.
    * Revenue fell 89% to $762.00 thousand from a year ago; 
analysts
expected $1.81 million. 
    * Yumanity Therapeutics Inc's reported EPS for the quarter
was a
loss of $1.00​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Yumanity Therapeutics Inc shares had fallen by 42.2% this
quarter.
    * The company reported a quarterly loss of $10.41 million.
    * Wall Street's median 12-month price target for Yumanity
Therapeutics Inc is $35.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 29 at 01:30 p.m.  ​All
figures in US dollars unless otherwise stated